3 Reasons Why Growth Investors Shouldn't Overlook Central Garden (CENTA)

Central Garden (CENTA), a pet and lawn products manufacturer, is highlighted by Zacks as a compelling growth investment, earning a Zacks Rank #1 (Strong Buy) and a Growth Score of B. This favorable outlook is driven by a projected 18.5% EPS growth this year, significantly outpacing the 1% industry average, and a robust 8.7% year-over-year cash flow growth, contrasting with the industry's -3.8%. Recent upward revisions in current-year earnings estimates further reinforce CENTA's potential for strong outperformance.

Analysis

Central Garden & Pet Company (CENTA) presents a compelling case for growth investors, underpinned by strong forward-looking financial metrics that significantly outperform its industry. The company is projected to deliver an 18.5% increase in EPS for the current year, a figure that starkly contrasts with the meager 1% growth expected for the industry average. This earnings momentum is supported by robust cash flow generation; CENTA's year-over-year cash flow has grown by 8.7%, while its industry peers have seen an average decline of 3.8%. Furthermore, the company's historical annualized cash flow growth of 11.4% over the past 3-5 years suggests a sustained ability to fund operations and new projects internally. The positive outlook is further reinforced by recent analyst activity, with the Zacks Consensus Estimate for current-year earnings having been revised upward by 0.4% in the last month, a trend empirically linked to near-term stock performance. These factors collectively contribute to its Zacks Rank #1 (Strong Buy) and Growth Score of B.

Key Decisions for Investors

• Given the projected 18.5% EPS growth and strong cash flow metrics that significantly outpace industry averages, growth-oriented investors should view CENTA as a compelling opportunity, an outlook supported by its Zacks #1 Rank.
• It is crucial to monitor upcoming earnings reports to validate that the company's performance aligns with the robust growth forecasts, as these projections are central to the stock's positive rating.
• Investors should continue to track the trend in earnings estimate revisions, as the recent upward revision in the Zacks Consensus Estimate is presented as a strong correlated indicator for near-term stock price movements.